In vitro protective effects of Ginkgo biloba against cisplatin toxicity in mouse cell line OCk3

Audiological Medicine

Volumn 6, Issue 4, 2008, Pages 251-258

  Astolfi, Laura ^a   Simoni, Edi ^a   Ciorba, Andrea ^a   Martini, Alessandro ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Antioxidant; Cisplatin; Ginkgo biloba; Hair cells; Inner ear protection; OCk3

Indexed keywords

ACUVAL; CISPLATIN; GINKGO BILOBA EXTRACT; GINKGOSELECT; GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CORTI ORGAN; EAR PROTECTION; HAIR CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; SPIRAL GANGLION; STRIA VASCULARIS;

EID: 57149088461     PISSN: 1651386X     EISSN: 16513835     Source Type: Journal    
DOI: 10.1080/16513860802527930     Document Type: Article

References (37)

1. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res. 2007;226:157-67.
2. Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, et al. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer. 1998;77:1355-62.
3. Rademaker-Lakhai JM, Crul M, Zuur L, Baas P, Beijnen JH, Simis YJW, et al. Relationship between cisplatin administration and the development of ototoxicity. J Clin Oncol. 2006;24:918-24.
4. Clerici WJ, DiMartino DL, Prasad MR. Direct effect of reactive oxygen species on cochlear outer hair cells. Hear Res. 1995;84:30-40.
5. van Ruijven MWM, de Groot JCMJ, Klis SFL, Smoorenburg G. Cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res. 2005;205:24-48.
6. Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol. 2000;21:513-20.
7. Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam Appl Toxicol. 1995;26:293-300.
8. Kopke RD, Liu W, Gabaizadeh R, Jacono A, Feghali J, Spray D, et al. The use of organotypic cultures of organ of Corti to study the protective effects of antioxidant molecules on cisplatin- induced damage of auditory hair cells. Am J Otol. 1997;18:559-71.
9. Rybak LP, Husain K, Evenson L, et al. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol Toxicol. 1997;81:173-9.
10. Wimmer C, Mees K, Stumpf P, et al. Round window application of D-methionine, sodium thiosulphate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol. 2004;25:33-40.
11. Maclennan KM, Darlington CL, Smith PF. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol. 2002;67:235-57.
12. Oztürk G, Anlar O, Erdogan E, Kösem M, Ozbek H, Türker A. The effect of Ginkgo extract EGb761 in cisplatin-induced peripheral neuropathy in mice. Toxicol Appl Pharmacol. 2004;196:169-75.
13. Wang G, Cao F, Chen J. Progress in researches on the pharmaceutical mechanism and clinical application of Ginkgo biloba extract on various kinds of diseases. Chin J Integr Med. 2006;12:234-9.
14. de Feudis FV, Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets. 2000;1:25-58.
15. Kaltenbach JA, Rachel JD, Mathog TA, Zhang J, Falzarano PR, Lewandowski M. Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus. J Neurophysiol. 2002;88:699-714.
16. Kalinec F, Kalinec G, Boukhvalova M, Kachar B. Establishment and characterization of conditionally immortalized organ of Corti cell lines. Cell Biol Int. 1999;23:175-84.
17. Bertolaso L, Martini A, Bindini D, Lanzoni I, Parmeggiani A, Vitale C, et al. Apoptosis in the OC-k3 immortalized cell line treated with different agents. Audiology. 2001;40:327-35.
18. Previati M, Lanzoni I, Astolfi L, Fagioli F, Vecchiati G, Pagnoni A, et al. Cisplatin cytotoxicity in organ of Corti-derived immortalized cells. J Cell Biochem. 2007;101:1185-97.
19. Previati M, Lanzoni I, Corbacella E, Magosso S, Giuffrè S, Francioso F, et al. RNA expression induced by cisplatin in an organ of Corti-derived immortalized cell line. Hear Res. 2004;196:8-18.
20. Feldenberg LR, Thevananther S, del Rio M, de Leon M, Devarajan P. Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am J Physiol Renal Physiol. 1999;276:F837-46.
21. van Cruchten S, van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol. 2002;31:214-23.
22. Low WK, Tan MJK, Sun L, Chua AVC, Goh LK, Wang DY. Dose-dependent radiation-induced apoptosis in a cochlear cell-line. Apoptosis. 2006;11:2127-36.
23. Guidetti C, Paracchini S, Lucchini S, Cambieri M, Marzatico F. Prevention of neuronal cell damage induced by oxidative stress in vitro: effect of different Ginkgo biloba extracts. J Pharm Pharmacol. 2001;53:387-92.
24. Zhou LJ, Zhu XZ. Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. J Pharmacol Exp Ther. 2000;293:982-8.
25. Chen JW, Chen YH, Lin FY, Chen YL, Lin SJ. Ginkgo biloba extract inhibits tumour necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23:1559-66.
26. Kang X, Chen J, Xu Z, Li H, Wang B. Protective effects of Ginkgo biloba extract on paraquat-induced apoptosis of PC12 cells. Toxicol In Vitro. 2007;21:1003-9.
27. Li G, Liu W, Frenz D. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS. NeuroToxicol. 2006;27:22-30.
28. van den Berg JH, Beijnen JH, Balm AJM, Schellensm JHM. Future opportunities in preventing cisplatin-induced ototoxicity. Cancer Treat Rev. 2006;32:390-7.
29. Lynch ED, Gu R, Pierce C, Kil J. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res. 2005;201:81-9.
30. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005;10:1313-21.
31. Korver K, Rybak LP, Whitworth C, Campbell KCM. Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg. 2002;126:683-9.
32. Campbell KC, Meech RP, Rybak LP, Hughes LF. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J Am Acad Audiol. 2003;14:144-56.
33. Ernst E, Stevinson C. Ginkgo biloba for tinnitus: a review. Clin Otolaryngol Allied Sci. 1999;24:164-7.
34. Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: double-blind, placebo- controlled trial. Br Med J. 2001;332:1-6.
35. Rybak LP, Whitworth C, Somani S. Application of antioxidants and other agents to prevent cisplation ototoxicity. Laryngoscope. 1999;109:1740-4.
36. Xu O, Lu H, Li PQ, et al. Effect of combination of ginkgo leaf extract and deferoxamine in preventing and treating ototoxicity of cisplatin. Chin J Integr Tradit West Med. 2004;24:915-8.
37. Huang X, Whitworth CA, Rybak LP. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol. 2007;28:828-33.